about
Vaccines against malariaImmune mechanisms in malaria: new insights in vaccine developmentEuropean Vaccine Initiative: lessons from developing malaria vaccinesA review of malaria vaccine clinical projects based on the WHO rainbow tableAlgae-produced Pfs25 elicits antibodies that inhibit malaria transmissionFlavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoesAn antibody against an Anopheles albimanus midgut myosin reduces Plasmodium berghei oocyst developmentDesigning the next generation of medicines for malaria control and eradicationVaccines against malariaMalaria vaccine: a future hope to curtail the global malaria burdenVaccines for malaria: how close are we?The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria VaccineThe structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine designFunctional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidateDomestic trends in malaria research and development in China and its global influenceA research agenda for malaria eradication: drugsA research agenda for malaria eradication: modelingMosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersVirosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & childrenUtilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models.Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malariaPhenotypic characterization of Plasmodium berghei responsive CD8+ T cells after immunization with live sporozoites under chloroquine coverMalaria vaccine research and development: the role of the WHO MALVAC committeeMolecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow.A research agenda to underpin malaria eradication.A research agenda for malaria eradication: monitoring, evaluation, and surveillanceA research agenda for malaria eradication: basic science and enabling technologiesNatural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria?The Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication.Strategies for designing and monitoring malaria vaccines targeting diverse antigensHitting hotspots: spatial targeting of malaria for control and eliminationPlasmodium vivax malaria vaccines: why are we where we are?Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisA research and development agenda for the control and elimination of human helminthiases.Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biologyDevelopment of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.
P2860
Q17485685-4AF624E8-1521-40D0-862F-23F3030C63F1Q21032484-12A08161-25FA-41A9-B1B4-5862120D6E40Q21032652-028D4175-4D8A-4ABE-A2B3-65A5CDD0EEA1Q21034112-FAAB870F-0D9F-48C9-A6D0-78E246D9950EQ21134576-DE856F77-22BC-4A40-81C3-E1C06B666E05Q24705181-A3192A70-9C64-4E71-82AA-4E417DC37FD1Q26315471-E0FFC800-81AC-4A7A-8EFF-D7328AA23DC3Q26859195-2987B46E-2C71-4E7B-A0CD-06B65CCE1CB5Q26995079-49426E84-665B-401C-A876-9FCE50F39109Q26996425-CFFA0B71-E0CB-4FFA-B83D-7B85025A158AQ27024344-613283D4-D45E-492B-812C-89C1DECF8A90Q27300745-DA810562-C1C7-43A5-8060-3B1629C94DD8Q27681234-27F7AD5C-DD8E-4FC4-AF30-5A6907E9784EQ28365035-1FECF8A8-E552-493E-90D2-3102019FFA7AQ28365208-E24B8635-E61B-4234-A9C0-EB2753C4088AQ28476806-EDC0ECD7-798D-422C-91B5-2D6EDB4FFC9AQ28476808-68E841B5-FA60-4744-8141-33FF9CB66709Q28482471-01012C86-831D-4FE0-901F-C8EA0A55B3D1Q28742277-C70895F6-D1CD-423C-8405-C4773F6123A3Q30243982-26290528-EEE7-4903-8577-4AFE16677A81Q30386746-B1C1F360-CC52-443A-B82E-46760B8CAD3CQ30983587-14BA01D0-9234-42B2-9935-1AB68919109DQ31139546-6F30AB01-02DF-4CC6-9307-922FCA277A81Q33558847-2B8A56BE-7759-4A1A-9D4E-7196F06ED509Q33611463-CB2587E2-EDEB-4789-A4D3-592290890CC9Q33794320-9188B95A-A86A-4463-8FB1-DB24A588FD55Q33818020-B13F49F7-A9D1-425A-9EB8-261237ADC04DQ33818025-89DB0BC7-D303-489D-87F1-285F49D8CF57Q33818036-EFC98E31-E608-45A7-8782-45775ED32D7AQ33834779-3D666A0F-94E0-40FF-84B7-3089B9EEDDC3Q33841040-A696F059-3BEF-4F5F-8468-CA2D15AD0F5AQ33957657-E0545405-210F-4A09-9745-7819D785A465Q33959038-8346FB6A-644D-45AC-8340-EA4B380A11BEQ34149880-9466DAB5-05D5-4CCC-AC74-1F0948E19F6BQ34170071-9AA363FD-6F3E-4812-A9C0-85B4EE45F775Q34234390-DE46BAC2-B041-4504-92B5-B1885A09791FQ34251402-F6E1CF21-2FF8-47A2-8B94-A8F56BDDF602Q34298647-5829EE9E-CA59-4F6F-9F83-714D92D365E0Q34303401-C34E3AF4-C4DA-4E9E-A69B-56F59E2FC9C2Q34341570-E9EAC7F0-9B33-4C2F-BAE9-E50D53D36BE3
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A research agenda for malaria eradication: vaccines.
@ast
A research agenda for malaria eradication: vaccines.
@en
type
label
A research agenda for malaria eradication: vaccines.
@ast
A research agenda for malaria eradication: vaccines.
@en
prefLabel
A research agenda for malaria eradication: vaccines.
@ast
A research agenda for malaria eradication: vaccines.
@en
P2860
P1433
P1476
A research agenda for malaria eradication: vaccines.
@en
P2093
malERA Consultative Group on Vaccines
P2860
P304
P356
10.1371/JOURNAL.PMED.1000398
P407
P5008
P577
2011-01-25T00:00:00Z